Time course of vascular arginase expression and activity in spontaneously hypertensive rats

C Demougeot, A Prigent-Tessier, T Bagnost, C André… - Life sciences, 2007 - Elsevier
There is growing evidence that vascular arginase plays a role in pathophysiology of
vascular diseases. We recently reported high arginase activity/expression in young adult …

[HTML][HTML] Misregulation of the arginase pathway in tissues of spontaneously hypertensive rats

T Bagnost, A Berthelot, M Alvergnas… - Hypertension …, 2009 - nature.com
There is a growing evidence that arginase has a role in the pathophysiology of
cardiovascular diseases including hypertension. We recently reported arginase …

Treatment with the arginase inhibitor Nω-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat

T Bagnost, A Berthelot, M Bouhaddi… - Journal of …, 2008 - journals.lww.com
Objective High vascular arginase activity and subsequent reduction in vascular nitric oxide
production were recently reported in animal models of hypertension. The present study …

Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile

NN Huynh, KL Andrews, GA Head, SML Khong… - …, 2009 - Am Heart Assoc
Arginase upregulation is associated with aging and cardiovascular diseases. In this study
we report on the cardiovascular phenotype of the arginase II knockout (KO) mouse. We …

Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension

T Bagnost, L Ma, RF Da Silva… - Cardiovascular …, 2010 - academic.oup.com
Aims Growing evidence suggests that arginase misregulation plays a key role in the
pathophysiology of essential hypertension. In the present study, we investigated the …

Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats

C Demougeot, A Prigent-Tessier, C Marie… - Journal of …, 2005 - journals.lww.com
Objective A decrease in nitric oxide (NO) bioavailability has been proposed to contribute to
endothelial dysfunction and increased peripheral resistances during essential arterial …

Arginase pathway in human endothelial cells in pathophysiological conditions

T Bachetti, L Comini, G Francolini, D Bastianon… - Journal of molecular and …, 2004 - Elsevier
Objective.–Arginase is a nitric oxide synthase-alternative pathway for l-arginine breakdown
leading to biosynthesis of urea and l-ornithine. Arginase pathway is inducible by …

Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension

FK Johnson, RA Johnson… - American Journal of …, 2005 - journals.physiology.org
Vascular tissues express arginase that metabolizes l-arginine to l-ornithine and urea and
thus reduces substrate availability for nitric oxide formation. Dahl salt-sensitive (Dahl-S) rats …

Diabetes-induced vascular dysfunction involves arginase I

MJ Romero, JA Iddings, DH Platt… - American Journal …, 2012 - journals.physiology.org
Arginase can cause vascular dysfunction by competing with nitric oxide synthase for l-
arginine and by increasing cell proliferation and collagen formation, which promote vascular …

Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production

HM El-Bassossy, R El-Fawal, A Fahmy - Vascular pharmacology, 2012 - Elsevier
Increased arginase activity has been reported in a variety of disease conditions
characterized by vascular dysfunction. In the present study, the potentially protective effect of …